| Nancy J Burnside, MD | |
|
333 School St, Suite 216, Pawtucket, RI 02860-5334 | |
| (401) 728-6990 | |
| (401) 729-0930 |
| Full Name | Nancy J Burnside |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 333 School St, Pawtucket, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659396224 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD09795 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nancy J Burnside, MD 333 School St, Suite 216, Pawtucket, RI 02860-5334 Ph: (401) 728-6990 | Nancy J Burnside, MD 333 School St, Suite 216, Pawtucket, RI 02860-5334 Ph: (401) 728-6990 |
News Archive
A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease (COPD).
The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.
Convincing the nation's most vulnerable citizens to avoid costly emergency department visits is proving harder than expected. A new study from the University of Iowa found improving access to affordable primary care reduced preventable hospital stays for black and Hispanics who receive both Medicare and Medicaid but failed to reduce the number of trips to the emergency department.
A multicenter team of researchers, including scientists at Columbia University Medical Center (CUMC), Brigham and Women's Hospital (BWH), Mount Sinai School of Medicine, and Massachusetts Institute of Technology, has developed biodegradable nanoparticles that are capable of delivering inflammation-resolving drugs to sites of tissue injury.
› Verified 3 days ago
Ms. Maeve Riane Tobin, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 333 School St Ste 112a, Pawtucket, RI 02860 Phone: 401-728-6990 | |
Paul T Zaydon, MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 115 Newport Ave, Pawtucket, RI 02861 Phone: 401-723-4290 Fax: 401-723-4830 | |
Neil E Toback, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 333 School Street, Ste 216, Pawtucket, RI 02860 Phone: 401-728-6990 Fax: 401-729-0930 | |
David S Pomerantz, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 333 School Street, Suite #216, Pawtucket, RI 02860 Phone: 401-728-6990 Fax: 401-729-0930 |